Cargando…

Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia

BACKGROUND: Tuberculosis is a communicable disease that is a major cause of ill health, one of the top 10 causes of death worldwide, and the leading cause of death from a single infectious agent, even ranking above human immuno-deficiency virus (HIV/AIDS). OBJECTIVE: To assess the prevalence and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gebretsadik, Daniel, Ahmed, Nuru, Kebede, Edosa, Mohammed, Miftah, Belete, Melaku Ashagrie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247715/ https://www.ncbi.nlm.nih.gov/pubmed/32547120 http://dx.doi.org/10.2147/IDR.S248059

Ejemplares similares

Knowledge, attitude, practice towards COVID-19 pandemic and its prevalence among hospital visitors at Ataye district hospital, Northeast Ethiopia
por: Gebretsadik, Daniel, et al.
Publicado: (2021)

Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection
por: Georghiou, Sophia B., et al.
Publicado: (2021)

Rifampicin-resistant Mycobacterium tuberculosis by GeneXpert MTB/RIF and Associated Factors Among Presumptive Pulmonary Tuberculosis Patients in Nepal
por: Sah, Shiv Kumar, et al.
Publicado: (2020)

Evaluation of stool GeneXpert MTB/RIF for the diagnosis of pulmonary tuberculosis among presumptive patients in Tanzania
por: Ngadaya, Esther, et al.
Publicado: (2020)

Role of GeneXpert MTB/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance
por: Mukhida, Sahjid, et al.
Publicado: (2022)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018)

GeneXpert—A Game-Changer for Tuberculosis Control?
por: Evans, Carlton A.
Publicado: (2011)

GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis
por: Talib, Abu, et al.
Publicado: (2019)

Comparison of GeneXpert and line probe assay for detection of Mycobacterium tuberculosis and rifampicin-mono resistance at the National Tuberculosis Reference Laboratory, Kenya
por: Aricha, S. A., et al.
Publicado: (2019)

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India
por: Sarin, Sanjay, et al.
Publicado: (2019)

Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
por: Atashi, S., et al.
Publicado: (2017)

Detection of Mycobacterium Tuberculosis and Rifampicin-Resistant Gene among Hemodialysis Patients in Khartoum, Sudan: Using GeneXpert Assay
por: Mohamed, Balsam Adil, et al.
Publicado: (2020)

Detection of Mycobacterium tuberculosis and Rifampicin Resistance Using GeneXpert MTB/RIF Assay at Enat Hospital, Central Ethiopia
por: Selfegna, Sebsib, et al.
Publicado: (2022)

Assessment of the Diagnostic Utility of GeneXpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) Assay in the Suspected Cases of Tuberculous Meningitis
por: Patel, Sakshi, et al.
Publicado: (2023)

Prevalence of rifampicin resistant pulmonary tuberculosis using geneXpert assay in Ethiopia, a systematic review and meta-analysis
por: Demelash, Maritu, et al.
Publicado: (2023)

Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis patients in Addis Ababa, Ethiopia from 2014 to 2021
por: Diriba, Getu, et al.
Publicado: (2022)

Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia
por: Jaleta, Kefyalew N, et al.
Publicado: (2017)

An observational report of universal GeneXpert testing of inpatients with diagnosed or presumptive TB in the Philippines
por: Thi, Aye Myat, et al.
Publicado: (2020)

Surveillance of Rifampicin Resistance With GeneXpert MTB/RIF in the National Reference Laboratory for Tuberculosis at the Institut Pasteur in Bangui, 2015–2017
por: Farra, Alain, et al.
Publicado: (2019)

Surveillance for multi-drug and rifampicin resistant tuberculosis and treatment outcomes among previously treated persons with tuberculosis in the era of GeneXpert in rural eastern Uganda
por: Izudi, Jonathan, et al.
Publicado: (2020)

Diagnostic Accuracy of Sputum Microscopy in Comparison With GeneXpert in Pulmonary Tuberculosis
por: Umair, Masab, et al.
Publicado: (2020)

Effectiveness of GeneXpert(®) in the diagnosis of tuberculosis in people living with HIV/AIDS
por: de Faria, Mariana Gaspar Botelho Funari, et al.
Publicado: (2021)

Molecular Epidemiology of Rifampicin Resistance in Mycobacterium tuberculosis Using the GeneXpert MTB/RIF Assay from a Rural Setting in India
por: Reddy, Raghuprakash, et al.
Publicado: (2017)

Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria
por: Ikuabe, Peter Ogie, et al.
Publicado: (2018)

Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert(®) MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia
por: Admassu, Wasihun, et al.
Publicado: (2022)

Efficacy and role of Xpert(®) Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis
por: Samuel, Benedict Paul, et al.
Publicado: (2018)

Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study
por: Masenga, Sepiso K., et al.
Publicado: (2017)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022)

Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
por: Habib, Zaiyad G., et al.
Publicado: (2015)

Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis
por: Moussa, Husseiny Sh., et al.
Publicado: (2016)

Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis
por: Mechal, Youness, et al.
Publicado: (2019)

GeneXpert on patients with human immunodeficiency virus and smear-negative pulmonary tuberculosis
por: Cuong, Nguyen Kim, et al.
Publicado: (2021)

GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
por: Saeed, Muhammad, et al.
Publicado: (2020)

Diagnosing an atypical case of tuberculosis presenting as dacryocystitis: Sac biopsy and GeneXpert
por: Lokdarshi, Gautam, et al.
Publicado: (2022)

Missed opportunities for integrated testing of HIV and tuberculosis on the GeneXpert platform in Lesotho
por: Gwaza, Gamuchirai P., et al.
Publicado: (2023)

Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia
por: Araya, Shambel, et al.
Publicado: (2020)

Analysis of the trend of malaria prevalence in Ataye, North Shoa, Ethiopia between 2013 and 2017
por: Feleke, Daniel Getacher, et al.
Publicado: (2018)

Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
por: Ajbani, Kanchan, et al.
Publicado: (2019)

Magnitude of Mycobacterium tuberculosis Infection and Its Resistance to Rifampicin Using Xpert-MTB/RIF Assay Among Presumptive Tuberculosis Patients at Motta General Hospital, Northwest Ethiopia
por: Demissie, Tesfaye Andualem, et al.
Publicado: (2021)

Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India
por: Singh, Urvashi B., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jm5gk7h0uu3ujt8l7renvr0ljp